Described herein are pharmaceutical packaging devices which reduce oxidative degradation of morphine, hydromorphone, promethazine and other oxygen-delicate medications, such units together with a syringe with the oxygen permeable suggestion cap, a hermetically sealed oxygen barrier blister packaging with quite very low permeability to oxygen and co